The lifetime risk of diabetic nephropathy is ---45% for patients with Type I (insulin-dependent) diabetes (1) and at least 30-35% for patients with Type II (noninsulin-dependent) diabetes (2, 3). In Type I diabetes,
the greater the increase, the more likely that there will be progression to clinically significant disease (conversely, the less likely that intervention will stop or reverse the progression). The term "microalbuminuria" is often used to refer to small amounts of albumin that fall below the detection limit of older assays for albumin. This term is misleading; it implies that there is a small molecular species of albumin, when in fact, the albumin in the urine of these patients is qualitatively no different from urinary albumin in other conditions. "Incipient nephropathy" is also a misnomer, because diabetic patients with even slightly increased albumin excretion already have the glomerular changes of diabetes by light microscopy (20 
